Treatment of diseases involving ErbB2 kinase overexpression

Details for Australian Patent Application No. 2004280257 (hide)

Owner Mars, Incorporated

Inventors Schmitz, Harold H.

Agent Watermark

Pub. Number AU-A-2004280257

PCT Pub. Number WO2005/034879

Priority 60/510,604 10.10.03 US

Filing date 8 October 2004

Wipo publication date 21 April 2005

International Classifications

A61K 31/353 (2006.01)

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/034879 Priority application(s): WO2005/034879

6 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280258-Method, apparatus and article for computational sequence generation and playing card distribution

2004280256-Pyrovalerone analogs and therapeutic uses thereof